No changes in anti-JCV antibody status after Natalizumab discontinuation in a large population of Multiple Sclerosis patients

被引：0
|
作者：
Sgarlata, E. [1 ,2 ]
Chisari, C. G. [3 ]
D'Amico, E. [3 ]
Toscano, S. [3 ]
Zanghi, A. [3 ]
Lo Fermo, S. [3 ]
Patti, F. [3 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Rome, Italy
[2] Umberto I Hosp, Dept Med, Siracusa, Italy
[3] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P658
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [31] Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy
    Outteryck, Olivier
    Ongagna, Jean-Claude
    Duhamel, Alain
    Zephir, Helene
    Collongues, Nicolas
    Lacour, Arnaud
    Fleury, Marie-Celine
    Berteloot, Anne-Sophie
    Blanc, Frederic
    Giroux, Marianne
    Vermersch, Patrick
    de Seze, Jorome
    JOURNAL OF NEUROLOGY, 2012, 259 (11) : 2293 - 2298
  • [32] Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab
    Maria Inmaculada Dominguez-Mozo
    Marta Garcia-Montojo
    Virginia De Las Heras
    Angel Garcia-Martinez
    Ana María Arias-Leal
    Ignacio Casanova
    Rafael Arroyo
    Roberto Alvarez-Lafuente
    Journal of Neuroimmune Pharmacology, 2013, 8 : 1277 - 1286
  • [33] Seroprevalence and seroconversion of anti-JCV antibodies in a cohort of multiple sclerosis patients
    Gomez-Estevez, I.
    Vasco, L. Garcia
    Suarez, E. Alba
    Hernandez, M. Castro
    Sanchez, C. Bullon
    Oreja-Guevara, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 531 - 531
  • [34] NATALIZUMAB-RELATED PML 2 WEEKS AFTER NEGATIVE ANTI-JCV ANTIBODY ASSAY
    Brosseau, Marie-Sarah Gagne
    Stobbe, Gary
    Wundes, Annette
    NEUROLOGY, 2016, 86 (05) : 484 - 486
  • [35] Anti-JCV antibodies in a Spanish multiple sclerosis cohort
    Dominguez-Mozo, M. I.
    Rus, M.
    Garcia-Martinez, M. A.
    Arias-Leal, A. M.
    Izquierdo, G.
    Arroyo, R.
    Alvarez-Lafuente, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 675 - 675
  • [36] Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy
    Clausi, V.
    Martelli, F.
    Repice, A. M.
    Mechi, C.
    Magnani, E.
    Massacesi, L.
    Azzi, A.
    Giannecchini, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 467 - 467
  • [37] Prevalence of anti-JCV antibodies in a cohort of multiple sclerosis patients from Italy
    Moiola, L.
    Sangalli, F.
    Martinelli, V.
    Bucello, S.
    Grimaldi, L. M.
    Baroncini, D.
    Ghezzi, A.
    Pace, A.
    Paes, D.
    Subramanyam, M.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2011, 258 : 149 - 149
  • [38] NATALIZUMAB-RELATED PML 2 WEEKS AFTER NEGATIVE ANTI-JCV ANTIBODY ASSAY Response
    Brosseau, Marie-Sarah Gagne
    Stobbe, Gary
    Wundes, Annette
    NEUROLOGY, 2016, 87 (09) : 957 - 958
  • [39] Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration
    Aoyama, Shinji
    Mori, Masahiro
    Uzawa, Akiyuki
    Uchida, Tomohiko
    Masuda, Hiroki
    Ohtani, Ryohei
    Kuwabara, Satoshi
    JOURNAL OF NEUROLOGY, 2018, 265 (05) : 1145 - 1150
  • [40] Anti-JCV antibody levels (index) in the population of Polish patients with multiple sclerosis (multicenter study in patients treated with immunomodulating or immunosuppressive drugs and naive patients)
    Bonek, R.
    Bochniak, P.
    Guenter, W.
    Karbicka, A.
    Jalowinski, R.
    Litwin, A.
    Kurowska, K.
    Wicha, W.
    Petit, V.
    Rejdak, K.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 394 - 395
12345